Natural killer cells (NK cells) are cells critical to the innate immune system, capable of responding rapidly to viral infections, tumor cells, and other pathogens. Unlike other immune cells, NK cells can quickly recognize and destroy diseased cells in the absence of antibodies, a characteristic that makes them play an important role in immune responses.
NK cells are called "natural killers" because they do not require activation to recognize cells that lack self-markers, a property that gives them a unique ability in the immune system.
Most immune cells rely on antigen presentation and major histocompatibility complex I (MHC-I) to recognize infected cells. However, NK cells do not rely on these mechanisms. NK cells recognize stressed cells, especially virus-infected or tumor cells that lack MHC-I markers. This "missing self-marking" recognition property symbolizes the importance of NK cells in tumor immune surveillance.
NK cells are derived from common innate lymphocyte precursors and enter the circulation system after differentiation and maturation in multiple organs such as bone marrow, lymph nodes, and spleen. The differentiation process of these cells in the human body is very complex and involves multiple cell signals and environmental influences.
CD56+ and CD3- NK cells have specific surface markers, which enable them to play special roles in a variety of immune responses.
The main functions of NK cells include identifying and killing infected cells and tumor cells. They use proteins in cytotoxic granules, such as perforin, and enzymes, such as granzymes, to trigger apoptosis, or cell death, by forming pores in the cell membrane. This mechanism not only destroys diseased cells, but also prevents the further spread of the virus.
Although NK cells are primarily considered part of the innate immune system, recent studies have shown that they can exhibit certain characteristics of adaptive immune cells, such as the ability to generate immune memory from past infections. This shows the potential application value of NK cells in defense against various pathogens and cancer.
NK cells not only play an important role in innate immunity, but have also begun to receive attention in adaptive immunity. They may become an important therapy for cancer and HIV treatment.
NK cells can also mediate antibody-dependent cell-mediated cytotoxicity (ADCC). When antibodies bind to antigens on the surface of diseased cells, the CD16 receptors of NK cells can recognize these antibodies, thereby activating NK cells and releasing lethal particles to destroy target cells.
With in-depth research on the functions of NK cells, the scientific community is full of expectations for their potential in cancer immunotherapy. The unique recognition mechanism of NK cells allows them to flexibly respond to various pathogens. Future research may explore how to use these cells more effectively to fight various diseases.
These mechanisms and properties make NK cells an important focus of future immunotherapy research. In the face of ever-changing pathogens and cancer cells, the flexibility and timely response capabilities of NK cells make people think: Can we further decode these cells and provide new solutions for future medical treatments?